Oldest pages
From Wikilite
Showing below up to 50 results starting with #1.
View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500)
- Free light chains and monoclonal gammopathies (08:10, 28 April 2009)
- Section 4 (13:40, 7 May 2009)
- Section 5 (13:41, 7 May 2009)
- SECTION 4 - General applications of free light chain assays (06:50, 21 May 2009)
- SECTION 5 - Practical aspects of serum free light chain testing (06:57, 21 May 2009)
- Preface to 1st editon 2003 (15:20, 27 May 2009)
- Preface to Epub Editon (06:52, 9 June 2009)
- Preface to 5th Editon (06:53, 9 June 2009)
- Preface to 5th edition (06:54, 9 June 2009)
- Preface to 1st edition 2003 (06:58, 9 June 2009)
- Data:right (19:44, 24 June 2009)
- Data:left (20:14, 24 June 2009)
- SECTION 6 - Appendices (18:43, 14 July 2009)
- SECTION 1 - Immunoglobulin free light chains and their analysis (09:39, 16 July 2009)
- Test (19:50, 26 October 2009)
- Test1 (20:37, 26 October 2009)
- Printed boxybar (19:33, 2 November 2009)
- Stefanhp:Old Things (08:09, 3 November 2009)
- New Things (20:39, 17 November 2009)
- Stefanhp:tables (06:43, 25 February 2010)
- 2010-Sep-Contents (17:00, 30 August 2010)
- 2010-Sep-Overview - The clinical importance of serum free light chain analysis (17:01, 30 August 2010)
- 2010-Sep-Introduction (17:09, 30 August 2010)
- 2010-Sep-Dr Bence Jones and the history of free light chains (17:17, 30 August 2010)
- 2010-Sep-Biology of immunoglobulin light chains (17:18, 30 August 2010)
- 2010-Sep-Sensitivity of serum free light chain assays (17:22, 30 August 2010)
- 2010-Sep-Intact immunoglobulin multiple myeloma (IIMM) - theoretical considerations of sFLC and Ig measurements (17:25, 30 August 2010)
- 2010-Sep-Intact immunoglobulin MM (IIMM) - sFLCs at diagnosis (17:26, 30 August 2010)
- 2010-Sep-Localised amyloid disease (17:30, 30 August 2010)
- 2010-Sep-Cerebrospinal fluid and free light chains (17:34, 30 August 2010)
- 2010-Sep-Implementation and interpretation of free light chain assays (17:37, 30 August 2010)
- 2010-Sep-Quality assurance for serum free light chain analysis (17:40, 30 August 2010)
- 2010-Sep-Preface to 5th edition (17:44, 30 August 2010)
- 2010-Sep-Preface to 1st edition 2003 (17:44, 30 August 2010)
- 2010-Sep-Dedication and Acknowledgements (17:45, 30 August 2010)
- Section 6 (07:52, 30 September 2010)
- Section 7 (07:55, 30 September 2010)
- 2011-March-Multiple myeloma - Introduction (21:13, 22 March 2011)
- Mar 2011 Serum versus urine tests for free light chains (12:52, 31 March 2011)
- Preface to 6th edition (13:45, 31 March 2011)
- Dedication and Acknowledgements (14:04, 31 March 2011)
- 2010-April-Guidelines for use of serum free light chain assays (14:39, 20 April 2011)
- 2011-April-Guidelines for use of serum free light chain assays (09:18, 26 April 2011)
- Overview - The clinical importance of serum free light chain analysis (07:46, 10 May 2011)
- Important notice (12:01, 24 May 2011)
- Preface and Abbreviations (07:47, 26 May 2011)
- Localised amyloid disease (14:09, 5 October 2011)
- Dec-2011-AL Amyloidosis (11:25, 30 November 2011)
- Main Page (14:42, 19 January 2012)
- Abbreviations (13:40, 21 February 2012)
